[Anagrelide. A selective inhibitor of thrombopoiesis].
Hasselbalch
H C
HC
Frederiksberg Hospital, medicinsk afdeling B.
Mourits-Andersen
H T
HT
Jensen
B A
BA
Nielsen
O J
OJ
D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D011799:Quinazolines / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology
D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D011799:Quinazolines; C021139:anagrelide
Anagrelid. En selektiv hoemmer af trombopoiesen.